Five Things to Know About Esketamine Sandhya Prashad, MD April 8, 2020 In March 2019, intranasal esketamine—a form of ketamine marketed as SPRAVATO™ CIII Nasal Spray*—was approved by the U.S. Food and Read More >
4 Things We Now Know About Treatment-Resistant Depression Sandhya Prashad, MD April 8, 2020 For many people coping with major depressive disorder—which includes different types of depression that persist for at least two weeks—antidepressants can Read More >